Watch out, Pfiz­er and Mod­er­na; An­ti-ag­ing break­through in mice?; Neu­ro for the new GSK; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

The End­points team will be en­joy­ing a long week­end in ob­ser­vance of In­de­pen­dence Day on Mon­day. If you’re ded­i­cat­ed enough to be read­ing this re­port, don’t miss my col­league Zachary Bren­nan’s ex­cel­lent vir­tu­al event — a fire­side chat fol­lowed by a pan­el — on the post-Covid FDA. You can watch it on-de­mand here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.